Dynamk Capital is a New York venture capital firm founded in 2017, investing in life science industrials — the tools, technologies, and services used to discover, develop, and manufacture cell and gene therapies.
Its dozen-plus portfolio spans cell therapy manufacturing and analytics, including RoosterBio (cell therapy raw materials, with recent partnerships spanning Nikon, ZEISS, and Secretome T...
Toronto, Canada
China
London, United Kingdom
San Francisco, United States
Santa Monica, United States
Northampton, United Kingdom